Department of Pediatrics & Dan L. Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA.
J Neurooncol. 2014 Feb;116(3):609-16. doi: 10.1007/s11060-013-1345-6. Epub 2014 Jan 5.
Malignant peripheral nerve sheath tumors (MPNSTs) are rare soft tissue sarcomas that arise predominantly from Schwann cells. Despite the fact that MPNSTs have high local recurrence rates and are generally associated with poor prognosis, little is known about prognostic factors or effective clinical management for this tumor type. The purpose of this study was to describe the distributions of patient and tumor characteristics and to identify predictors of cause-specific survival among MPNST cases reported to SEER between 1973 and 2008. Patient and tumor characteristics were compared between pediatric and adult MPNST cases. Cox regression and tree-based survival analysis were used to examine factors associated with MPNST-related mortality separately among adults and children. A total of 1,315 MPNST cases were isolated from the 1973-2008 SEER dataset. Among pediatric cases, sex, race, and radiation therapy predicted MPNST survival, whereas among adults, tumor site, tumor grade, number of primary tumors, and tumor size were significant predictors. As tumor size at diagnosis/resection may be the only somewhat "modifiable" prognostic factor, future studies should aim to identify biological and social attributes associated with tumor size at diagnosis, separately among individuals with and without NF-1, in order to help identify earlier opportunities for clinical intervention.
恶性外周神经鞘瘤(MPNST)是一种罕见的软组织肉瘤,主要起源于施万细胞。尽管 MPNST 具有较高的局部复发率,且通常与预后不良相关,但对于这种肿瘤类型的预后因素或有效临床管理方法知之甚少。本研究的目的是描述患者和肿瘤特征的分布,并确定 1973 年至 2008 年间 SEER 报告的 MPNST 病例的特异性生存预测因子。比较了儿科和成人 MPNST 病例的患者和肿瘤特征。Cox 回归和基于树的生存分析分别用于检查成人和儿童中与 MPNST 相关死亡率相关的因素。从 1973-2008 年 SEER 数据集共分离出 1315 例 MPNST 病例。在儿科病例中,性别、种族和放疗预测了 MPNST 的生存,而在成人中,肿瘤部位、肿瘤分级、原发性肿瘤数量和肿瘤大小是显著的预测因子。由于诊断/切除时的肿瘤大小可能是唯一具有一定“可改变性”的预后因素,因此未来的研究应旨在确定与无 NF-1 和 NF-1 个体的诊断时肿瘤大小相关的生物学和社会属性,以便为临床干预提供更早的机会。